Mary-Dell Chilton found the tool that let scientists rewrite a plant's genes, and in doing so helped launch one of the most consequential, and contested, revolutions in the history of farming. She died at 87, a pioneer honored with agriculture's highest prize and remembered, fondly, as the "queen of Agrobacterium."

The breakthrough

Dr. Chilton's insight grew from a plant disease. Studying crown gall, which forms tumor-like growths on plants, she and her collaborators worked out that the culprit, a soil bacterium called Agrobacterium tumefaciens, was in effect a natural genetic engineer: it slipped a piece of its own DNA into a plant's genome, where the plant then treated the foreign genes as its own. Dr. Chilton realized the process could be turned to human ends. Stripping out the disease-causing genes, her team used the disarmed bacterium as a delivery vehicle to insert new DNA into a tobacco plant. By 1982, they had produced the first genetically modified plant, and the trait passed down to the next generation, proving the technique worked.

From lab to farm

That method became a foundation of modern plant biotechnology. In 1983 Dr. Chilton left academia to build a corporate research program at what would become Syngenta, where she led the development of crops engineered to resist insects and tolerate herbicides. The genetically modified corn, soybeans and cotton that descended from her work now cover a huge share of American farmland and much of the crop acreage worldwide, changing how food is grown on a scale few scientists ever influence.

Honors, and controversy

The recognition was substantial. Dr. Chilton was inducted into the National Inventors Hall of Fame, elected to the National Academy of Sciences, and in 2013 shared the World Food Prize for her role in developing genetically engineered crops. Yet the field she helped create has never stopped generating argument. Critics have raised questions about the safety and ecological effects of engineered crops and about the concentration of agricultural power in a handful of large companies. Dr. Chilton's legacy sits squarely in that debate, her science credited with helping feed a growing world even as its applications remain culturally contested.

A scientist's life

Colleagues remembered a researcher of rigor and warmth who published widely and mentored a generation of plant scientists. Beyond the laboratory she was known for interests that had nothing to do with genes, including a fondness for the outdoors that lasted into her later years. Her death closes a career that began with a curiosity about why plants grow tumors and ended with a body of work that quietly reshaped the fields, and the food, of much of the planet. The questions she opened, about what humans should do with the power to edit living things, outlive her, and are only becoming more pressing.